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SUMMARY
Host restriction of influenza A virus limits pandemic
emergence. The viral RNA polymerase (vPol) is an
essential enzyme that must adapt for avian viruses
to replicate in humans. Species differences in
host ANP32A dictate adaptation: human ANP32A
lacks an uncharacterized 33 amino-acid insertion
that is present in avian ANP32A. Here, we uncover
important contributions of host SUMOylation to
vPol activity, including avANP32A function. We also
identify a hydrophobic SUMO interaction motif
(SIM)-like sequence unique to avANP32A that
critically supports avian-signature vPol. Unrelated
SIM sequences partially recapitulate this function
when introduced into huANP32A. By investigating
ANP32A-vPol interactions, we find that huANP32A
interacts weakly with both human- and avian-signa-
ture vPols, while the hydrophobic motif of avANP32A
promotes stronger interactions. Furthermore, we
identify a highly acidic stretch in avANP32A that con-
stitutes a major site of vPol interaction. Our data
suggest compensatory mechanisms underlying
vPol adaptation to host ANP32A independent of spe-
cies-specific interactions.
INTRODUCTION
Influenza A virus (IAV) RNA-dependent RNA polymerase (vPol) is
a heterotrimeric complex comprising polymerase acidic (PA),
polymerase basic 1 (PB1), and polymerase basic 2 (PB2) pro-
teins. Altogether, these subunits bind the 50 and 30 ends of the
viral RNA genome and act with the viral nucleoprotein (NP) to
form viral ribonucleoprotein complexes that complete RNA repli-
cation and transcription. A critical feature of IAV biology is that
replication and transcription take place in the nucleus of infected
cells, where vPol co-opts host machinery to function efficiently.
The PB2 subunit of vPol is a major contributor to host restric-
tion (Almond, 1977), which can be determined by the identity of
PB2 residue 627: PB2-627E is usually characteristic of avian-
signature IAVs, often limiting replication to avian cells, while
PB2-627K is an adaptive mutation characteristic of most
mammalian-signature IAVs (Subbarao et al., 1993). This host-
range phenotype is a consequence of host factor incompatibility
and can be observed in cell-based vPol reconstitution assays
using isogenic vPol pairs differing only in the identity of
PB2-627. The nuclear proteins ANP32A and ANP32B, which
serve functions in chromatin modification and remodeling (Reilly
et al., 2014), have been identified as interactors and functional
co-factors for vPol activity (Sugiyama et al., 2015). Furthermore,
a species-specific difference in ANP32A was found to determine
host restriction of vPol: a unique 33 amino-acid insertion in avian
ANP32A (avANP32A) that is not found in human ANP32A
(huANP32A), permits activity of avian-signature vPols containing
PB2-627E (Long et al., 2016). One hypothesis is that the rapid
selection of mammalian-signature vPol substitutions that occurs
during avian IAV infection of humans may be driven by adapta-
tion of vPol to engage the huANP32A ortholog lacking the critical
insertion.
We have demonstrated that IAV infection leads to global re-
programming of host SUMOylation (Domingues et al., 2015), a
ubiquitin-like modification reaction predominantly located in
the cell nucleus that regulates chromatin remodeling, transcrip-
tion, and DNA repair. vPol activity is a major contributor to small
ubiquitin-like modifier (SUMO) redistribution, suggesting an inti-
mate association between viral RNA replication and this post-
translational modification. Here, we characterize the interplay
further, uncovering a general contribution of host SUMOylation
to vPol activity. We find a role for SUMO in promoting
avANP32A-mediated avian-signature vPol function, which is
not related to SUMOmodification of avANP32A.Moreover, while
we observed a weak interaction between huANP32A and vPol
that is independent of PB2-627 identity, a SUMO interaction
motif (SIM)-like sequence in the unique insertion of avANP32A
enhances its interaction with vPol and determines restriction.
These data provide insights into avANP32A-mediated enhance-
ment of avian-signature vPols and suggest a model whereby
avian-signature vPol adaptation to humans relies on overcoming
consequences of weak huANP32A interaction, rather than
enhancing engagement directly.
RESULTS
SUMOylation Is Important for vPol Activity
Among human host proteins that change in SUMOylation status
during IAV infection (Domingues et al., 2015), we identified 18
cellular proteins previously described as vPol interactors
(Bradel-Tretheway et al., 2011), including ANP32A and
ANP32B (Figure 1A). To test the impact of SUMOylation on
ANP32A function with respect to vPol activity, we established
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an ANP32A-dependent mini-replicon vPol reporter system. As
expected, mini-replicon activity is highly efficient in human
293T cells when using a PB2-627K, but not PB2-627E, subunit
variant (>200-fold difference) (Figure 1B). However, activity of
the PB2-627E vPol can be enhanced significantly (150-fold)
by co-expression of chicken ANP32A (chANP32A), but not
huANP32A (Figure 1B). To manipulate host SUMOylation in
this chANP32A-dependent system, we generated a library en-
compassing V5-tagged variants of all known human nuclear
SUMO-specific proteases (SENP1–3, SENP5–7, and USPL1).
As shown in Figures 1C and 1D, SENP1, SENP2, SENP6,
and SENP7, as well as USPL1, efficiently promoted global
Figure 1. SUMOylation Is Important for vPol Activity
(A) IAV-induced SUMOylation changes to vPol interactors.
(B) Mini-replicon assay comparing PB2-627K and PB2-627E vPols in human cells and the impact of huANP32A and chANP32A.
(C and D) Impact of SUMO proteases on SUMO1 and SUMO2 conjugates. Western blot analysis of 293T cell lysates co-transfected for 24 hr with the indicated
V5-tagged SUMO protease, together with either 6X-His-tagged SUMO1 (C) or SUMO2 (D).
(E) Impact of SUMO proteases on chANP32A-mediated PB2-627E vPol activity. Experiment performed as in (B), except the indicated SUMO protease was co-
transfected.
(F) Impact of SUMO proteases on PB2-627K vPol activity.
(G) Specificity index of PB2-627E versus PB2-627K vPol activities in the presence of the indicated SUMO protease (original data from E and F; values represent
1  E/K ± SD).
In (B), (E), and (F), bars represent mean values from three independent experiments (±SD). Significance was determined by Student’s t test (*p < 0.05; **p < 0.01;
***p < 0.001; ****p < 0.0001; NS, non-significant).
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deconjugation of SUMO1 and SUMO2 from target substrates.
However, SENP3 and SENP5 exhibited specific deconjugation
activity toward SUMO2 substrates. Co-transfection of each
SUMO protease (except SENP6) reduced chANP32A-depen-
dent vPol activity, with the SUMO2-specific proteases SENP3
and SENP5 reducing activity up to 10-fold (Figure 1E). Some
SUMO proteases also affected activity of PB2-627K vPol com-
plexes (Figure 1F). However, the pattern of SUMO protease-
mediated inhibition of PB2-627E or PB2-627K vPol activities
differed, with a trend for the PB2-627K vPol to be less sensitive
to SUMO protease expression (Figure 1G). These data indicate
that SUMOylation is important for efficient vPol activity but sug-
gest that there is an additional role for SUMOylation in
chANP32A-mediated avian-signature vPol function.
chANP32A Contains a SIM-like Sequence that Promotes
Avian-Signature vPol Activity
Weassessedwhether direct SUMOylation of chANP32Aaffected
its function. To this end,wegeneratedchANP32Aconstructswith
lysine-to-arginine loss-of-function substitutions either at the re-
ported human ANP32B (huANP32B) SUMOylation site (resi-
due 68; conserved in chANP32A) (Hendriks et al., 2014) or at all
twenty lysine residues of the protein (termed K0). Immunoblot
analysis confirmed that all constructs expressed to comparable
levels (Figure 2A). chANP32A with the single K68R substitution
was as efficient as wild-type (WT) at promoting avian-signature
vPol activity (Figure 2B). Unexpectedly, substitution of all twenty
lysine residues in chANP32A only affected its ability to promote
PB2-627E vPol activity to a small degree (2-fold) (Figure 2B),
which was clearly not comparable to that observed for SUMO
protease co-expression. In addition, expression of most SUMO
proteases still negated the vPol promoting function of the
chANP32A-K0 construct to a similar extent as their effect on
WT chANP32A (Figures 2C and 2D). SENP2 appeared to be
more specific to WT chANP32A and had no impact on the func-
tion of chANP32A-K0, suggesting that this SUMO protease
may antagonize a specific SUMOylation event on chANP32A
that plays a minor role in promoting vPol activity. Nevertheless,
most SUMO proteases were still highly active against
chANP32A-K0-dependent vPol activity, indicating that the
impact of SUMOylation on vPol activity is largely independent
of ANP32A SUMOylation. These data imply that other SUMO-
dependent mechanisms contribute to regulating chANP32A-
dependent vPol activity.
The 33 amino-acid insertion after position 175, which is unique
to chANP32A, comprises 6 novel amino-acid residues and a 27
amino-acid duplication of residues 149–175 (Figure 2E). The
novel amino acids include an arrangement of hydrophobic resi-
dues (VLSLV) that resembles a SIM. Functional SIMs are often
surrounded by stretches of acidic residues, which also play an
important role during SIM-dependent interactions. Such an
arrangement is also observed in the chANP32A protein, in which
the hydrophobic residues are directly flanked to the N-terminal
side by an 8 amino-acid stretch of acidic residues, and additional
acidic residues and stretches are found in the C-terminal 27
amino-acid duplication (Figure 2E). Substitution of these hydro-
phobic residues for glycines severely affected the ability of
chANP32A to support PB2-627E vPol activity, while substitu-
tions at other non-hydrophobic positions in this motif did not
alter activity (Figures 2F and 2G). When all four hydrophobic
residues were substituted for glycines, the resulting chANP32A
construct was effectively inactive, behaving similarly to
huANP32A with respect to promoting PB2-627E containing
vPol function (Figure 2G). None of the chANP32A mutant con-
structs negatively affected the PB2-627K vPol to a significant
extent (Figure 2H), indicating a specific enhancing effect of these
residues on PB2-627E. Changes to the hydrophobic patch of
chANP32A did not affect either protein expression levels or intra-
cellular localization (Figures 2I and 2J). These data indicate that
the unique hydrophobic stretch of amino acids in chANP32A that
resembles a SIM-like sequence is critical for promoting avian-
signature vPol activity.
Insertion of Heterologous SIM Sequences into
huANP32A Partially Permits Avian-Signature vPol
Activity
Using in vitro SUMO binding assays, we could not detect a
strong interaction between chANP32A and purified SUMO1 or
SUMO2 compared with the well-characterized SIM-containing
protein PIASxa (PIAS2) (Figures 3A–3C). The interaction between
many bona fide SIMs and purified SUMO is known to be both
transient and of very low affinity; consequently, such interactions
can be difficult to detect in standard biochemical assays (Taupitz
et al., 2017). We therefore used a genetic gain-of-function
approach to assess the contribution of the chANP32A SIM-like
sequence on avian-signature vPol activity. While huANP32A is
incapable of promoting PB2-627E vPol function, a chimeric
huANP32A construct harboring the unique 33 amino-acid inser-
tion from chANP32A is fully able to support vPol activity (Figures
3D and 3E) (Long et al., 2016). We found that similar to the 33
amino acids from chANP32A, insertions of well-characterized,
heterologous SIM sequences from PIAS2 or PIAS4 were able
to partially enhance the ability of huANP32A to promote PB2-
627E vPol activity, despite their divergent sequences and
lengths (Figures 3D and 3E). All chimeric constructs expressed
to similar levels (Figure 3F), and in vitro SUMObinding assays us-
ing the chimeric constructs revealed that the strong PIAS2 and
PIAS4 SIMs were functional (Figure 3G). Overall, these results
indicate that bona fide SIM sequences from unrelated human
proteins can partially functionally replace the unique 33 amino-
acid insert of chANP32A.
chANP32A Exhibits Enhanced Interaction with vPol
Complexes,which IsMediated by theSIM-like Sequence
and LCAR
huANP32A was previously shown to interact with the human-
adapted vPol to regulate viral genome synthesis (Sugiyama
et al., 2015). We therefore tested the hypothesis that chANP32A
is able to support PB2-627E vPol activity by exhibiting a higher
affinity toward this avian-signature complex than the huANP32A
ortholog. As shown in Figure 4A, we confirmed that huANP32A
can weakly co-precipitate the PB2-627E vPol complex and
further found that chANP32A interacts more efficiently with this
complex. Surprisingly, this enhanced interaction of chANP32A
with vPol was not specific to PB2-627E, because chANP32A
also showed greater interaction with the human-signature
2540 Cell Reports 20, 2538–2546, September 12, 2017
Figure 2. chANP32A Contains a SIM-like Sequence Important for Promoting PB2-627E vPol Activity
(A) Western blot analysis of lysates from 293T cells transfected with the indicated constructs.
(B) SUMOylation of chANP32A minimally affects PB2-627E vPol activity. chANP32A-K68R and chANP32A-K0 were tested for their abilities to promote PB2-
627E/K vPol activities, as described in Figure 1B.
(C) Impact of SUMO proteases on chANP32A-K0 function during PB2-627E vPol activity. Experiment performed as in Figure 1E.
(D) Specificity index of chANP32A-WT- versus chANP32A-K0-mediated PB2-627E vPol activities in the presence of the indicated SUMO protease (original data
from Figure 1E and C; values represent 1  K0/WT ± SD).
(legend continued on next page)
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PB2-627K vPol (Figure 4A). Similarly, we found that the
weaker co-precipitation of vPol by huANP32A is independent
of PB2-627 identity. The enhanced interaction of chANP32A
with the vPol complex is mediated by the SIM-like sequence in
the unique 33 amino-acid insertion of chANP32A, because sub-
stitution of the key hydrophobic residues for glycines severely
affected the ability of chANP32A to precipitate vPol (Figure 4A).
These results reveal that chANP32A exhibits a greater propen-
sity than huANP32A to interact with vPol in co-transfected cells
but that this does not correlate with the identity of PB2-627.
Furthermore, the requirement of the SIM-like sequence in
chANP32A for mediating this enhanced interaction suggests
that an additional SUMO-modified factor could stabilize the
chANP32A-vPol complex.
To better understand the chANP32A-vPol interaction, we
constructed a series of additional chANP32A mutants and
examined their ability to co-precipitate the viral complex and
support vPol activity. chANP32A, by homology to huANP32A,
consists of an N-terminal leucine-rich repeat (LRR) domain
flanking the 33 amino-acid insert that contains the SIM-like
sequence. In addition, the C-terminal part of chANP32A com-
prises a low-complexity acidic region (LCAR), with the only
recognizable motif being a short stretch of basic amino-acid
residues near the C terminus that make up a nuclear localiza-
tion signal (NLS) (Figure 4B). Because the ANP32A LRR domain
is highly structured, and small deletions likely lead to global un-
folding of this domain, we focused our mutational analysis on
the LCAR, producing a series of C-terminal deletions. All
mutant constructs expressed equally well, suggesting that
they were stable, and as expected, removal of the NLS pre-
vented absolute retention of chANP32A in the nucleus so that
a more even nuclear-cytoplasmic distribution was observable
(Figure 4C). Deletion of the C-terminal 46 residues of
chANP32A, which includes the NLS, had a relatively minor
impact on the ability of chANP32A to promote PB2-627E vPol
function. In contrast, a chANP32A mutant construct lacking
61 residues (chANP32A-220) was more severely compromised
in promoting vPol activity (Figure 4D). Interaction analyses re-
vealed that chANP32A-220 was the most defective at co-
precipitating vPol, although binding of the chANP32A-235
construct was also affected (Figure 4E). These data define
chANP32A residues 221–235 as major determinants of vPol
binding and contributors to PB2-627E vPol activity. This partic-
ular region is an almost contiguous stretch of 14 acidic resi-
dues, suggesting that this association with vPol is mediated
by electrostatic interactions. Side-by-side comparisons re-
vealed that the vPol interaction mediated by chANP32A resi-
dues 221–235 is more essential than that mediated by the
SIM-like sequence (Figure 4F), even though mutation of the
SIM-like sequence has a greater impact on reducing the ability
of chANP32A to promote PB2-627E vPol function (Figure 4G).
These data suggest that although strong interaction of
chANP32A to vPol is important for overcoming PB2-627E
host restriction, the most critical determinant of activity is integ-
rity of the SIM-like sequence.
DISCUSSION
Herein, we show that host SUMOylation plays an important role
during vPol activity. Expanding on this, we provide evidence that
a SUMO-dependent function may contribute to the ability of
avANP32A to interact with, and promote activity of, avian-signa-
ture vPols. We identified a critical role for a hydrophobic motif in
the unique 33 amino-acid insertion of avANP32A that, together
with surrounding acidic residue stretches, shows a striking
resemblance to SIM-like sequences that normally mediate
non-covalent interactions with SUMO. Although we were unable
to show that this hydrophobic sequence in avANP32A can
directly bind purified SUMO1 or SUMO2 in vitro, we used genetic
gain-of-function experiments to highlight that unrelated heterol-
ogous SIM sequences can to some extent functionally replace
the SIM-like sequence in avANP32A. The lack of full complemen-
tation by these heterologous SIM sequences may be due to
unknown differences with certain unique features of the
avANP32A SIM-like sequence that dictate SUMO paralog spec-
ificity or binding orientation. However, our observations suggest
that if the hydrophobic motif in avANP32A constitutes a func-
tional SIM, then the direct interaction with isolated SUMO is
probably weak, a property also exhibited by many bona fide
SIM-containing proteins (Taupitz et al., 2017). It may be that
the SIM-like sequence in avANP32A only shows affinity for
SUMO that is conjugated to a particular host or viral factor.
Host factors previously implicated in contributing toward vPol
restriction, such as importin family members, RIG-I, TUFM,
and DDX17 (Bortz et al., 2011; Gabriel et al., 2011; Kuo et al.,
2017; Weber et al., 2015), have also been reported to be
SUMOmodified (Hendriks et al., 2014; Hu et al., 2017; Lamoliatte
et al., 2014; Mooney et al., 2010; Wen et al., 2014). We speculate
that avANP32A stably engages with vPol via a SUMO-modified
viral or host factor.
The huANP32A protein was previously shown to interact with a
trimeric human-adapted vPol complex (Sugiyama et al., 2015).
Here, we made the surprising finding that huANP32A interacts
weakly with both human- and avian-signature vPols and that
avANP32A exhibits an enhanced interaction with the vPol com-
plex (also independent of PB2-627 identity) that is dependent
upon the hydrophobic SIM-like sequence. We additionally iden-
tified a highly acidic stretch of 15 amino acids in the ANP32A
(E) (Top) Sequence analysis of the region surrounding the 33 amino-acid insertion in chANP32A. Hydrophobic residues (pink) and acidic stretches (blue), which
comprise a SIM-like sequence, are highlighted. (Bottom) Alignment of bona fide SIM sequences from various human proteins.
(F) Panel of chANP32A mutants generated.
(G and H) Impact of chANP32A SIM-like sequence on PB2-627E (G) or PB2-627K (H) vPol activity. Experiment performed as in (B).
(I) Western blot analysis of 293T cell lysates from (G).
(J) Immunofluorescence analysis of the indicated FLAG-chANP32A proteins in transfected MRC5 cells. Scale bars represent 10 mm.
In (B), (C), (G), and (H), bars represent mean values from three independent experiments (±SD). Significance was determined by Student’s t test (*p < 0.05;
**p < 0.01; ***p < 0.001; ****p < 0.0001; NS, non-significant).
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LCAR (residues 221–235) that appear critical for interaction with
vPol yet are not as important as the SIM-like sequence for
promoting vPol activity. Given these observations, it seems
unlikely that selection of the viral PB2-627K adaptive mutation
in human cells is directly due to favored species-specific binding
toward the shorter mammalian ANP32A protein. Nevertheless, it
is clear that a functional correlation exists between species
differences in ANP32A length and vPol host adaptation (Long
et al., 2016). Thus, our data may support a working model
whereby the mammalian-adapted vPol (e.g., PB2-627K) arises
to compensate for weak or transient recruitment of huANP32A,
perhaps by increasing efficiency of huANP32A use, rather
than by enhancing binding. This would also suggest that avian-
adapted PB2 is inefficient at using ANP32A, but this is compen-
sated in avian cells by the strong and stable interaction of
avANP32A with vPol, potentially via a SUMO-modified factor,
Figure 3. Heterologous SIM Sequences Permit huANP32A to Promote PB2-627E vPol Activity
(A) Panel of constructs used and their respective SIM-like sequences.
(B and C) In vitro SUMO binding assays. Recombinant 6X-His tagged SUMO1 (B) or SUMO2 (C) was added to the indicated pre-immobilized FLAG-tagged
constructs. Subsequently, precipitated proteins were detected by western blot.
(D) Sequence alignment of huANP32A chimeric constructs generated to include the 33 amino-acid insertion of chANP32A or heterologous SIM sequences from
modified PIASxa or PIAS4. Hydrophobic residues (pink) and acidic stretches (blue), which comprise SIM-like sequences, are highlighted.
(E) Impact of heterologous SIM sequences on the ability of huANP32A to promote PB2-627E vPol activity. Experiment performed as in Figure 1B. Bars represent
mean values from three independent experiments (±SD). Significance was determined by Student’s t test (*p < 0.05; **p < 0.01).
(F) Western blot analysis of 293T cell lysates from (E).
(G) In vitro SUMO-binding assay performed with the huANP32A chimeric constructs as described in (B).
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which permits a longer interplay between PB2-627E and
ANP32A. Although hypothetical, such a model would agree
with the breakthrough finding that vPol must adapt to host-spe-
cific ANP32A (Long et al., 2016) while integrating previous
models detailing host adaptation mediated by vPol strategies
to increase functional efficiency (Paterson et al., 2014; Rameix-
Welti et al., 2009).
In summary, we provide evidence that SUMOylation contrib-
utes to vPol activity and that a unique hydrophobic SIM-like
sequence in avANP32A promotes interaction with vPol and is
critical to overcome vPol host restriction mediated by avian-
signature PB2-627E. Our work contributes to understanding of
the interplay between mammalian and avian vPol complexes
and a key host-range determinant.
Figure 4. chANP32A Exhibits Enhanced Interaction with Avian- and Mammalian-Signature vPol Complexes via the SIM-like Sequence
and LCAR
(A) 293T cells were transfected with the indicated FLAG-tagged constructs, together with PB1, PA, and PB2 (627E or 627K). Following anti-FLAG precipitation,
the indicated proteins were detected by western blot. Representative data from three independent experiments are shown.
(B) Schematic representation of chANP32A. LRR, leucine-rich repeat (repeats 1–5 indicated); LCAR, low-complexity acidic region; SLS, SIM-like sequence; NLS,
nuclear localization signal.
(C) Immunofluorescence analysis of the indicated FLAG-chANP32A proteins in transfected MRC5 cells. Scale bars represent 10 mm.
(D) (top) Impact of chANP32A LCAR truncations on PB2-627E vPol activity. Experiment performed as in Figure 1B. (bottom) Western blot analysis of 293T cell
lysates from top.
(E and F) Relative impact of chANP32A LCAR truncations (E) and chANP32A-mut3 (F) on PB2-627E vPol interaction. Experiments performed as in (A). Repre-
sentative data from three independent experiments are shown.
(G) Relative impact of chANP32A LCAR truncations and chANP32A-mut3 on PB2-627E vPol activity. Experiments performed as in Figure 1B.
In (D) and (G), bars represent mean values from three independent experiments (±SD). Significance was determined by Student’s t test (*p < 0.05; **p < 0.01;
***p < 0.001; ****p < 0.0001).
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EXPERIMENTAL PROCEDURES
Cells
293T cells were maintained in DMEM supplemented with 10% (v/v) fetal calf
serum, 100 units/mL of penicillin, and 100 mg/mL of streptomycin. MRC5 cells
were maintained in Eagle’s minimal essential medium (EMEM) supplemented
with 10% (v/v) fetal calf serum, 100 units/mL of penicillin, 100 mg/mL of strep-
tomycin, 2 mM L-glutamine, and 1% (v/v) non-essential amino acids.
Plasmids
Sequences of human SENP1–3, SENP5–7, and USPL1 were PCR amplified
from existing plasmids (gifts from Edward Yeh orWade Harper [Addgene plas-
mids #17357, #18047, #18048, #18053, #18065, #42886, and #22607]) (Bawa-
Khalfe et al., 2012; Cheng et al., 2007; Dou et al., 2010; Gong and Yeh, 2006;
Kang et al., 2010; Sowa et al., 2009) and ligated in frame into a modified
pCAGGS vector to express with N-terminal V5 tags. Codon-optimized se-
quences of huANP32A-WT, chANP32A-WT, chANP32A-K0, huANP32A+33,
huANP32A+P2*-SIM, and huANP32A+P4-SIM were generated using the
GeneArt gene synthesis service (Thermo Fisher Scientific) and ligated in frame
into p3xFLAG-CMV-7.1 (Sigma-Aldrich) so as to express with N-terminal
FLAG tags. The plasmid expressing FLAG-hPIASxa was a gift from Ke Shuai
(Addgene plasmid #15209) (Arora et al., 2003). pCAGGS-GST-V5, pLVX-6X-
His-SUMO1, and pCAGGS-6X-His-SUMO2 plasmids were generated by stan-
dard methods. The expression plasmid for FLAG-tagged mCherry has been
described previously (Domingues et al., 2015). Indicated additional gene
variants, as well as any required nucleotide corrections, were generated by
Quikchange II XL Site-Directed Mutagenesis (Agilent Technologies). New
constructs were authenticated by DNA sequencing. All plasmid transfections
were performed using FugeneHD (Promega) at a 1:3 DNA:transfection reagent
ratio.
Mini-replicon Assays
2 3 105 293T cells were co-transfected with pPolI-A/WSN/33 (WSN)-FFluc
(negative-sense viral-like Firefly luciferase reporter), pRL-SV40 (constitutive
Renilla luciferase reporter) (Promega), and pCAGGS expression vectors
encoding WSN PA, PB1, and PB2 (627E or 627K) and NP (at a ratio of
1:2:2:4:2 for PA:PB1:PB2:NP:reporter), together with the indicated amount
of the plasmids of interest. pRL-SV40 was used as a normalization control.
24 hr later, cells were harvested and luciferase activity was measured using
the Dual-Glo Luciferase Assay system (Promega).
Co-immunoprecipitation Assays
For SUMO-binding assays, 293T cells (23 106 in a 25 cm2 flask) were trans-
fected for 48 hr with 3 mg of the indicated FLAG-tagged construct before lysis
in buffer A (50 mM HEPES [pH 7.5], 100 mM NaCl, 50 mM KCl, 0.25% NP-40,
and 1 mM DTT), supplemented with 5 mM b-glycerophosphate, 1 mM sodium
orthovanadate, 25mMNaF, and a cOmpleteMini EDTA-free protease inhibitor
cocktail (Roche). Following sonication and centrifugation (13,000 rpm, 20 min,
and 4C), the soluble lysate fractions were incubated end over end at 4C for
2 hr with anti-FLAG M2 Affinity Agarose beads (Sigma). Precipitated immune
complexes were washed extensively in buffer A before recombinant human
His-SUMO1 (UL-715, Boston Biochem) or His-SUMO2 (UL-752, Boston Bio-
chem) was added at a concentration of 2 mg/mL and reactions were incubated
end over end at 4C for 16 hr. Protein-bead complexes were further washed in
buffer A before elution in 23 urea disruption buffer (6 M urea, 2 M b-mercap-
toethanol, and 4% SDS).
For vPol interaction assays, 293T cells (23 106 in a 25 cm2 flask) were co-
transfected with 3 mg of the indicated FLAG-tagged construct, together with
pCAGGS vectors expressing PA (0.5 mg), PB1 (1.5 mg), and PB2 (1.5 mg).
48 hr later, cells were lysed in buffer A supplemented with 20 mM iodoaceta-
mide (IAA), 5 mM b-glycerophosphate, 1 mM sodium orthovanadate, 25 mM
NaF, and a cOmplete Mini EDTA-free protease inhibitor cocktail (Roche).
Following sonication and centrifugation (as earlier), the soluble lysate fractions
were incubated end over end at 4C for 16 hr with anti-FLAG beads. Precipi-
tated immune complexes were further washed in buffer A supplemented
with 20 mM IAA and were eluted from the beads using 23 urea disruption
buffer.
Western Blot Analyses
Samples were lysed 1:1 in 23 urea disruption buffer, sonicated, and then
boiled for 10 min before SDS-PAGE on NuPAGE Novex 4%–12% Bis-Tris
gradient gels (Thermo Fisher Scientific). Proteins were detected by western
blotting after transfer to polyvinylidene fluoride (PVDF) or nitrocellulose mem-
branes using the following antibodies: IAV-PB1 (cc11), IAV-PB2 (polyclonal
anti-serum), IAV-PA (9016) (gifts from Silke Stertz), FLAG M2 (Sigma, F1804),
6X-His tag (Abcam, ab18184), actin (Sigma, A2103), or V5 tag (Bio-Rad,
MCA1360).
Immunofluorescence Imaging
MRC5 cells transfected with the indicated FLAG-tagged constructs for 24 hr
were fixed, permeabilized, and stained with anti-FLAG M2 antibody (Sigma,
F1804) as described (Domingues et al., 2015). Images were taken on a Leica
SP5 confocal microscope.
Statistics
Statistical analyses were performed using an unpaired two-tailed Student’s
t test. The p values for significance are stated in the figure legends.
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